cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Biomarin Pharmaceutical Inc
51 own
25 watching
Current Price
$64.85
$0.43
(0.67%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
16,803.76M
52-Week High
52-Week High
94.85000
52-Week Low
52-Week Low
60.63000
Average Volume
Average Volume
1.05M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
965.9684
iconMarket Capitalization16,803.76M
icon52-Week High94.85000
icon52-Week Low60.63000
iconAverage Volume1.05M
iconDividend Yield--
iconP/E Ratio965.9684
What does the Biomarin Pharmaceutical Inc do?
BioMarin Pharmaceutical Inc. (BioMarin) is a biotechnology company, which is engaged in developing and commercializing therapies that address the root cause of genetic conditions. BioMarin's commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide). Vimizim is an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder. The Roctavian is an adeno associated virus (AAV5) vector gene therapy designed to restore factor VIII plasma concentrations in patients with severe hemophilia A. Voxzogo is a once daily injection analog of C-type Natriuretic Peptide (CNP) for the treatment of achondroplasia. Brineura is a recombinant human tripeptidyl peptidase 1 (TPP1) for the treatment of patients with CLN2, a form of Batten disease.
Read More
How much money does Biomarin Pharmaceutical Inc make?
News & Events about Biomarin Pharmaceutical Inc.
TipRanks Financial Blog
1 year ago
In a report released yesterday, Geoff Meacham from Bank of America Securities maintained a Buy rating on BioMarin Pharmaceutical (BMRN Research R... In a report released yesterday, Geoff Meacham from Bank of America Securities maintained a Buy rating on BioMarin Pharmaceutical (BMRN &#8211...
Zolmax
1 year ago
BioMarin Pharmaceutical (NASDAQ:BMRN Get Rating) had its price objective decreased by Guggenheim from $125.00 to $120.00 in a report published on Thursday morning, The Fly reports. Other equities research analysts have also recently issued reports about the stock. Oppenheimer cut shares of BioMarin ...
Ticker Report
1 year ago
AIA Group Ltd lifted its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN Get Rating) by 168.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 4,313 shares of the biotechnology companys stock after ...
Zolmax
1 year ago
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN Get Rating) CEO Jean Jacques Bienaime sold 10,000 shares of the companys stock in a transaction dated Thursday, April 6th. The stock was sold at an average price of $96.13, for a total transaction of $961,300.00. Following the completion of the transaction, ...
PR Newswire
1 year ago
BioMarin Provides Update on FDA Review of ROCTAVIAN (Valoctocogene Roxaparvovec) Gene Therapy for Adults with Severe Hemophilia A BioMarin Provides Update on FDA Review of ROCTAVIAN (Valoctocogene Roxaparvovec) Gene Therapy for Adults with Severe Hemophilia A PR Newswire SAN RAFAEL, Calif., March...
Frequently Asked Questions
Frequently Asked Questions
What is Biomarin Pharmaceutical Inc share price today?
plus_minus_icon
Can Indians buy Biomarin Pharmaceutical Inc shares?
plus_minus_icon
How can I buy Biomarin Pharmaceutical Inc shares from India?
plus_minus_icon
Can Fractional shares of Biomarin Pharmaceutical Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Biomarin Pharmaceutical Inc stocks?
plus_minus_icon
What is today’s traded volume of Biomarin Pharmaceutical Inc?
plus_minus_icon
What is today’s market capitalisation of Biomarin Pharmaceutical Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Biomarin Pharmaceutical Inc?
plus_minus_icon
What percentage is Biomarin Pharmaceutical Inc down from its 52-Week High?
plus_minus_icon
What percentage is Biomarin Pharmaceutical Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$64.85
$0.43
(0.67%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00